Tatsuo Yamamoto

Short-term prediction of preeclampsia using the sFlt-1/PlGF ratio: a subanalysis of pregnant Japanese women from the PROGNOSIS Asia study

A. Ohkuchi, H. Masuyama, S. Saito, 2021, Hypertension Research.

Economic evaluation of the sFlt-1/PlGF ratio for the short-term prediction of preeclampsia in a Japanese cohort of the PROGNOSIS Asia study

A. Ohkuchi, H. Masuyama, S. Saito, 2021, Hypertension Research.

Increased serum levels of sFlt-1/PlGF ratio in preeclamptic women with onset at <32 weeks compared with ≥32 weeks.

C. Hirashima, S. Matsubara, A. Ohkuchi, 2018, Pregnancy hypertension.

Short-Term Prediction of Adverse Outcomes Using the sFlt-1 (Soluble fms-Like Tyrosine Kinase 1)/PlGF (Placental Growth Factor) Ratio in Asian Women With Suspected Preeclampsia

K. Tan, Joong-Shin Park, A. Ohkuchi, 2019, Hypertension.

Expert consensus: Indication criteria and screening strategy for preeclampsia using the serum sFlt-1/PlGF ratio at 18–36 weeks of gestation in women at imminent/basal risk of preeclampsia under insurance coverage

A. Ohkuchi, S. Makino, S. Saito, 2020, Hypertension Research in Pregnancy.